David Bruce Milne - 04 Mar 2022 Form 4 Insider Report for ASENSUS SURGICAL, INC.

Role: Director
Signature: /s/Joshua Weingard, as Attorney-in-Fact for David B. Milne
Issuer symbol: N/A
Transactions as of: 04 Mar 2022
Net transactions value: +$234,786
Form type: 4
Filing time: 08 Mar 2022, 07:00:11 UTC
Previous filing: 02 Jul 2021
Next filing: 15 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ASXC	Common Stock	Purchase	$31,885	+50,000	+20%	$0.6377	294,884	04 Mar 2022	Direct	F1
transaction	ASXC	Common Stock	Purchase	$32,115	+50,000	+17%	$0.6423	344,884	04 Mar 2022	Direct	F2
transaction	ASXC	Common Stock	Purchase	$31,745	+50,000	+14%	$0.6349	394,884	04 Mar 2022	Direct	F3
transaction	ASXC	Common Stock	Purchase	$30,325	+50,000	+13%	$0.6065	444,884	07 Mar 2022	Direct	F4
transaction	ASXC	Common Stock	Purchase	$61,550	+100,000	+22%	$0.6155	544,884	07 Mar 2022	Direct	F5
transaction	ASXC	Common Stock	Purchase	$3,571	+5,768	+1.1%	$0.6191	550,652	07 Mar 2022	Direct	F6
transaction	ASXC	Common Stock	Purchase	$43,595	+69,232	+13%	$0.6297	619,884	07 Mar 2022	Direct	F7, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6305 to $0.64 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F2	The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6385 to $0.6485 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F3	The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6325 to $0.64 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F4	The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6051 to $0.6136 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F5	The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.61 to $0.6161 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F6	The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6161 to $0.62 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F7	The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6232 to $0.63 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F8	The securities held following the reported transactions include 29,231 Restricted Stock Units granted on July 1, 2021. Forfeiture restrictions will lapse on such Restricted Stock Units on the first anniversary of the date of grant, or, if earlier, on the date of the Company's 2022 annual meeting of stockholders.